NCT00367913View on ClinicalTrials.gov

Clarithromycin v Ciprofloxacin Added to Rifampicin + Ethambutol, for Opportunist Mycobacterial Pulmonary Disease

PHASE4CompletedINTERVENTIONAL

Enrollment

400

Participants

Timeline

Start Date

March 31, 1995

Study Completion Date

September 30, 2004

Conditions

Pulmonary Diseases

Interventions

DRUG

Addition of clarithromycin to rifampicin and ethambutol

DRUG

Addition of Ciprofloxacin to rifampicin and ethambutol

BIOLOGICAL

Vaccination with M.vaccae

Trial Locations (1)

CF64 2XX

Llandough Hospital, Penarth

All Listed Sponsors

lead

British Thoracic Society

OTHER

NCT00367913 - Clarithromycin v Ciprofloxacin Added to Rifampicin + Ethambutol, for Opportunist Mycobacterial Pulmonary Disease | Biotech Hunter | Biotech Hunter